|Mr. James S. Hamilton||Pres, CEO & Director||357.49k||N/A||N/A|
|Mr. Mario Paradis CPA, CA||VP & CFO||210.29k||N/A||N/A|
|Mr. Michel Timperio||Pres of Cannabis Bus.||204.58k||N/A||N/A|
|Mr. François-Karl Brouillette||VP of Science and Innovation||166.21k||N/A||N/A|
|Mr. Marc Vaugeois||VP of Sales - Canada||165.89k||N/A||N/A|
Neptune Technologies & Bioressources Inc., a nutrition products company, focuses on providing nutrition solutions, including specialty ingredients and consumer brands. The company develops solutions available in various delivery forms. It also offers various specialty ingredients, including premium krill oil and other marine oils, as well as seed oils. The company sells its premium krill oil under the OCEANO3 brand directly to consumers through oceano3.com in Canada and the United States. In addition, it is pursuing opportunities in the prescription drug markets, through its subsidiary, Acasti Pharma Inc., that focuses on the research, development, and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment of severe hypertriglyceridemia. Neptune Technologies & Bioressources Inc. has an agreement with Tetra Bio-Pharma Inc. for the co-development, commercialization, and marketing of purified cannabinoid oil-based products to address pain and inflammation relief applications for the natural health products and pet veterinary markets. The company was founded in 1925 and is headquartered in Laval, Canada.
Neptune Technologies & Bioressources Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.